SpineGuard and Omnia Medical Announce the Signature of a Binding Term Sheet for the Transfer of SpineGuard Inc.
OrthoSpineNews
APRIL 10, 2025
PsiFGuard is now part of Omnia Medicals comprehensive product offering for ambulatory sacro-iliac joint fusion procedures, a fast growing segment. The latter was cleared by the FDA in September 2024 then officially launched at the end of January 2025 at the NANS (North American Neuromodulation Society) convention in Orlando. OmniaMedical.com.
Let's personalize your content